Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Artemisinin, a natural compound from Asteraceae family, is a key antimalarial drug.
• Artemisinin and its derivatives exhibit selective anticancer properties.
• Limitations hinder the repurposing of artemisinin derivatives as anticancer agents.

Purpose of the Study:

• To review the current landscape of artemisinin-derived hybrids with anticancer potential.
• To discuss synthetic strategies for creating these hybrids.
• To explore structure-activity relationships for rational drug design.

Main Methods:

• Literature review of studies on artemisinin-derived hybrids.
• Analysis of synthetic approaches for hybridization.
• Evaluation of structure-activity relationships.

Main Results:

• Hybridization of artemisinin with pharmacophores enhances anticancer activity.
• Tailoring hybridization partners improves target interaction and pathway modulation.
• Several artemisinin-derived hybrids show significant anticancer potential.

Conclusions:

• Artemisinin-derived hybrids represent a promising strategy to overcome limitations of artemisinin as an anticancer agent.
• Understanding synthetic routes and structure-activity relationships is crucial for developing effective anticancer drug candidates.
• Further research into artemisinin hybridization can lead to novel cancer therapeutics.